
HEMOCLOT™ Factor VIIa — FVIIa Clotting Assay for Bypassing Therapy
Price:
$659.00
Product DescriptionFor Research Use Only. Not for Use in Diagnostic Procedures. Clotting assay for activated Factor VII (FVIIa) activity in purified medium or citrated plasma. For monitoring recombinant FVIIa (eptacog alfa/NovoSeven®) bypassing agent therapy in hemophilia A with inhibitors. CE-IVD.
Product Characteristics
Product Components
|
Product ApplicationsFor the measurement of Factor VIIa activity in research applications. |